← All patents

US20230374138A1

Icos targeting for neuropathic pain relief

University of Texas at Dallas

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a primary dose-limiting side effect caused by antineoplastic agents, such as paclitaxel. This causes damage to peripheral nerves and the dorsal root ganglia (DRG). Currently, there are no effective treatments for CIPN, which can lead to long- …

University
University of Texas at Dallas
Assignee
Board Of Regents, The University Of Texas System
Inventor
Theodore J. Price
Priority date
May 17, 2022
Filing date
April 24, 2023
Publication date
November 23, 2023
Language
en
Metadata fetched
August 28, 2026 19:16